CALIFORNIA | LOCAL
May 7, 1992 |
Two types of experimental surgical procedures have significantly improved the conditions of patients with Parkinson's disease, surgeons said here Wednesday. Two teams of researchers independently reported that in a total of 11 patients, grafts of fetal tissue obtained during abortions sharply reduced tremors and rigidity and increased control of limb functions.
April 3, 1992 |
The Senate lifted a federal ban on fetal tissue transplant research, with a majority that could override a threatened presidential veto. A bill covering the issue was approved 87 to 10 and was sent to a conference committee. The House passed a similar measure in July. The Ronald Reagan and George Bush administrations imposed the moratorium on grounds that using the tissue for human transplants would cause an increase in the number of abortions.
October 9, 1991 |
For the first time, scientists have been able to convert muscle tissue into bones of a precise shape, potentially providing an important new source of bone for grafts and wound repairs. Researchers from Washington University in St. Louis and the National Institutes of Health combined muscle tissue from the legs of rats with finely ground bone powder, added a synthetically produced growth factor and injected the mixture into a rubber mold.
August 1, 1991 |
Pioneering medical research frequently provokes ethical controversies. But no research initiative in American medicine has evoked more genuine dishonesty or more hypocrisy than the use of fetal tissue transplants to help treat victims of Parkinson's disease, diabetes and other crippling illnesses. This controversy offers a shameful example of medical innovation mismanagement. At the center of this controversy are the products of abortion: dead fetuses.
May 19, 1991 |
An organ transplant company reported Saturday that two people who received tissue from an AIDS-infected man have preliminarily tested positive for the deadly virus. A spokesman for LifeNet Transplantation Services, the agency that distributed the man's tissue and organs, said the two had received particularly risky "fresh-frozen" tissue grafts, which were not treated with alcohol for fear that the chemical might kill the cells. A third recipient has been identified and will be tested, he said.
May 18, 1991 |
Health officials continued to search Friday for 50 or more transplant recipients who may have received organs, tissue or bone grafts from a donor whose infection with the AIDS virus had gone undetected. While the potential danger of AIDS infection from organ transplants is not unknown, this is believed to be the largest number of patients affected by a single donor, federal health officials said.
April 26, 1991 |
The new director of the National Institutes of Health said Thursday that while she continues to believe that it is acceptable to use fetal tissue for biomedical research, she will abide by the ban on federal funding for such work "without hesitation." Dr. Bernadine P.
April 18, 1991 |
The first fetal-to-fetal tissue transplant in the United States demonstrates how physicians and parents are willing to test the boundaries of medical knowledge in an attempt to cure fatal childhood diseases. The deceptively simple experimental procedure was performed in May, 1990, by Dr. R. Nathan Slotnick of the UC Davis School of Medicine who said this week he was "still in limbo" about whether it was successful.
April 16, 1991 |
A Texas couple who described themselves as anti-abortion told congressmen Monday, in often emotional testimony, why they decided to undergo a fetus-to-fetus tissue transplant in attempting to save their unborn child. "We do not agree with abortion," said the Rev. Guy Walden, a Baptist minister from Houston, his voice breaking at times. But "we believed that . . . this would be consistent with a pro-life, anti-abortion position." Theirs was the first public report of such surgery.
March 26, 1991 |
The Supreme Court on Monday let stand the ruling of a California court that a hospital patient does not own rights to tissues taken from his body, even if they prove immensely valuable to scientists. The high court action ends a financial threat to the burgeoning field of biotechnology. By genetically altering human cells, medical researchers have been able to produce new treatments for a variety of ailments including cancer, diabetes, hepatitis and ulcers.